Chemokine‐like factor 1 (CKLF1) aggravates neointimal hyperplasia through activating the NF‐κB /VCAM‐1 pathway
Neointimal hyperplasia (NIH) is a complicated inflammatory process contributing to vascular restenosis. The present study aimed to explore whether chemokine‐like factor 1 (CKLF1) aggravates NIH via the nuclear factor‐kappa B (NF‐κB)/vascular cell adhesion molecule‐1 (VCAM‐1) pathway. We found the ex...
Main Authors: | Xinnong Liu, Chengjia Qu, Yongbao Zhang, Jie Fang, Lequn Teng, Rujiao Zhang, Xiangyu Zhang, Chenyang Shen |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-09-01
|
Series: | FEBS Open Bio |
Subjects: | |
Online Access: | https://doi.org/10.1002/2211-5463.12942 |
Similar Items
-
CKLF1 aggravates neointimal hyperplasia by inhibiting apoptosis of vascular smooth muscle cells through PI3K/AKT/NF-κB signaling
by: Yanyu Duan, et al.
Published: (2019-09-01) -
Exosomes derived from mesenchymal stem cells inhibit neointimal hyperplasia by activating the Erk1/2 signalling pathway in rats
by: Zhihui Liu, et al.
Published: (2020-06-01) -
Prevention of neointimal formation using miRNA-126-containing nanoparticle-conjugated stents in a rabbit model
by: Izuhara, Masayasu
Published: (2018) -
Effects of Low Endothelial Shear Stress After Stent Implantation on Subsequent Neointimal Hyperplasia and Clinical Outcomes in Humans
by: Koki Shishido, et al.
Published: (2016-09-01) -
PARP1 deficiency protects against hyperglycemia-induced neointimal hyperplasia by upregulating TFPI2 activity in diabetic mice
by: Zhao-yang Wang, et al.
Published: (2021-10-01)